We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Supplements Lead to More Burdens Than Standard Filings, Tufts Finds
Supplements Lead to More Burdens Than Standard Filings, Tufts Finds
May 11, 2012
NDA and BLA supplements have created more headaches for pharma companies than standard new drug or biologic applications, finds a new study from the Tufts Center for the Study of Drug Development.